Authors:
HOLLOWAY MK
WAI JM
HALGREN TA
FITZGERALD PMD
VACCA JP
DORSEY BD
LEVIN RB
THOMPSON WJ
CHEN LJ
DESOLMS SJ
GAFFIN N
GHOSH AK
GIULIANI EA
GRAHAM SL
GUARE JP
HUNGATE RW
LYLE TA
SANDERS WM
TUCKER TJ
WIGGINS M
WISCOUNT CM
WOLTERSDORF OW
YOUNG SD
DARKE PL
ZUGAY JA
Citation: Mk. Holloway et al., A-PRIORI PREDICTION OF ACTIVITY FOR HIV-1 PROTEASE INHIBITORS EMPLOYING ENERGY MINIMIZATION IN THE ACTIVE-SITE (VOL 38, PG 308, 1995), Journal of medicinal chemistry, 39(11), 1996, pp. 2280-2280
Authors:
HOLLOWAY MK
WAI JM
HALGREN TA
FITZGERALD PMD
VACCA JP
DORSEY BD
LEVIN RB
THOMPSON WJ
CHEN LJ
DESOLMS SJ
GAFFIN N
GHOSH AK
GIULIANI EA
GRAHAM SL
GUARE JP
HUNGATE RW
LYLE TA
SANDERS WM
TUCKER TJ
WIGGINS M
WISCOUNT CM
WOLTERSDORF OW
YOUNG SD
DARKE PL
ZUGAY JA
Citation: Mk. Holloway et al., A-PRIORI PREDICTION OF ACTIVITY FOR HIV-1 PROTEASE INHIBITORS EMPLOYING ENERGY MINIMIZATION IN THE ACTIVE-SITE, Journal of medicinal chemistry, 38(2), 1995, pp. 305-317
Authors:
VACCA JP
DORSEY BD
SCHLEIF WA
LEVIN RB
MCDANIEL SL
DARKE PL
ZUGAY J
QUINTERO JC
BLAHY OM
ROTH E
SARDANA VV
SCHLABACH AJ
GRAHAM PI
CONDRA JH
GOTLIB L
HOLLOWAY MK
LIN J
CHEN IW
VASTAG K
OSTOVIC D
ANDERSON PS
EMINI EA
HUFF JR
Citation: Jp. Vacca et al., L-735,524 - AN ORALLY BIOAVAILABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR, Proceedings of the National Academy of Sciences of the United Statesof America, 91(9), 1994, pp. 4096-4100
Authors:
DORSEY BD
LEVIN RB
MCDANIEL SL
VACCA JP
GUARE JP
DARKE PL
ZUGAY JA
EMINI EA
SCHLEIF WA
QUINTERO JC
LIN JH
CHEN IW
HOLLOWAY MK
FITZGERALD PMD
AXEL MG
OSTOVIC D
ANDERSON PS
HUFF JR
Citation: Bd. Dorsey et al., L-735,524 - THE DESIGN OF A POTENT AND ORALLY BIOAVAILABLE HIV PROTEASE INHIBITOR, Journal of medicinal chemistry, 37(21), 1994, pp. 3443-3451